Pricing

Foamix Pharmaceuticals Ltd (FOMX)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
CEO:
Dov Tamarkin
Employees:
68
2 HOLZMAN ST., WEIZMANN SCIENCE PARK, REHOVOT, L3, 76704
97289316233

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Foamix Pharmaceuticals Ltd. engages in the development and commercialization of proprietary minocycline foam for the treatment of acne, impetigo, and other skin conditions. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available